Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Dempsie, Yvonne ^a   Nilsen, Margaret ^a   White, Kevin ^a   Mair, Kirsty M ^a   Loughlin, Lynn ^a   Ambartsumian, Noona ^b   Rabinovitch, Marlene ^c   MacLean, Margaret R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CALVASCULIN; ESTRADIOL; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; PROTEIN S 100; S100A4 PROTEIN, MOUSE;

AIRWAY REMODELING; ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; GENDER BIAS; GENE ACTIVATION; GENE EXPRESSION; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE HYPERTROPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; NEUROFIBROMA; NONHUMAN; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; STATISTICAL ANALYSIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; CBA MOUSE; CELL CULTURE; CELL PROLIFERATION; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE PRESSURE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; TRANSGENIC MOUSE; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ESTRADIOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; PULMONARY ARTERY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S100 PROTEINS; SEX FACTORS; SIGNAL TRANSDUCTION; UP-REGULATION; VENTRICULAR FUNCTION, RIGHT; VENTRICULAR PRESSURE;

EID: 83655181464     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-159     Document Type: Article

References (30)

1. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006, 173:1023-1030. 10.1164/rccm.200510-1668OC, 16456139.
2. Peacock AJ, Murphy NF, McMurray JJ, Caballero L, Stewart S. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 2007, 30:104-109. 10.1183/09031936.00092306, 17360728.
3. Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007, 30:1103-1110. 10.1183/09031936.00042107, 17804449.
4. Farhat MY, Chen MF, Bhatti T, Iqbal A, Cathapermal S, Ramwell PW. Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol 1993, 110:719-723. 2175952, 8242243.
5. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary-hypertension of chronic hypoxia and on recovery. American Journal of Physiology 1981, 240:H62-H72.
6. Greenway S, van Suylen RJ, Sarvaas GD, Kwan E, Ambartsumian N, Lukanidin E, Rabinovitch M. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol 2004, 164:253-262. 10.1016/S0002-9440(10)63115-X, 1602221, 14695338.
7. Merklinger SL, Wagner RA, Knutsen RH, Kabir G, Desai K, Hacker S, Cann GM, Ambartsumian N, Lukanidin E, Husain M, et al. Fibulin-5 may protect against pulmonary vascular obliterative disease in mice overexpressing Mts1 (S100A4). Circulation 2004, 110:19.
8. Spiekerkoetter E, Alvira CM, Kim YM, Bruneau A, Pricola KL, Wang L, Ambartsumian N, Rabinovitch M. Reactivation of gamma HV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin. American Journal of Physiology-Lung Cellular and Molecular Physiology 2008, 294:L276-L289.
9. Hansmann G, de JPV, Alastalo TP, Alvira CM, Guignabert C, Bekker JM, Schellong S, Urashima T, Wang L, Morrell NW, et al. An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. J Clin Invest 2008, 118:1846-1857. 10.1172/JCI32503, 2276393, 18382765.
10. Lawrie A, Spiekerkoetter E, Martinez EC, Ambartsumian N, Sheward WJ, MacLean MR, Harmar AJ, Schmidt AM, Lukanidin E, Rabinovitch M. Interdependent serotonin transporter and receptor pathways regulate S100A4/Mts1, a gene associated with pulmonary vascular disease. Circ Res 2005, 97:227-235. 10.1161/01.RES.0000176025.57706.1e, 16002749.
11. Lane KB, Machado RD, Pauciulo MW, Thomson JR, Phillips JA, Loyd JE, Nichols WC, Trembath RC. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 2000, 26:81-84.
12. Spiekerkoetter E, Guignabert C, Perez VD, Alastalo TP, Powers JM, Wang LL, Lawrie A, Ambartsumian N, Schmidt AM, Berryman M, et al. S100A4 and bone morphogenetic protein-2 codependently induce vascular smooth muscle cell migration via phospho-extracellular signal-regulated kinase and chloride intracellular channel 4. Circulation Research 2009, 105:639-U37. 10.1161/CIRCRESAHA.109.205120, 2818124, 19713532.
13. Xu HL, Vetri F, Lee HK, Ye S, Paisansathan C, Mao L, Tan F, Pelligrino DA. Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process. Am J Physiol Heart Circ Physiol 2009, 297:H2059-2067. 10.1152/ajpheart.00445.2009, 2793130, 19820198.
14. Tesarova P, Kalousova M, Jachymova M, Mestek O, Petruzelka L, Zima T. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer. Cancer Invest 2007, 25:720-725. 10.1080/07357900701560521, 18058469.
15. Ambartsumian N, Klingelhofer J, Grigorian M, Karlstrom O, Sidenius N, Georgiev G, Lukanidin E. Tissue-specific posttranscriptional downregulation of expression of the S100A4(mts1) gene in transgenic animals. Invasion & Metastasis 1999, 18:96-104.
16. Keegan A, Morecroft I, Smillie D, Hicks MN, MacLean MR. Contribution of the 5-HT1B receptor to hypoxia-induced pulmonary hypertension - Converging evidence using 5-HT1B-receptor knockout mice and the 5-HT1B/1D-receptor antagonist GR127935. Circ Res 2001, 89:1231-1239. 10.1161/hh2401.100426, 11739290.
17. Yang XD, Long L, Southwood M, Rudarakanchana N, Upton PD, Jeffery TK, Atkinson C, Chen HL, Trembath RC, Morrell NW. Dysfunctional smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circulation Research 2005, 96:1053-1063. 10.1161/01.RES.0000166926.54293.68, 15845886.
18. White K, Dempsie Y, Nilsen M, Wright AF, Loughlin L, MacLean MR. The serotonin transporter, gender, and 17beta oestradiol in the development of pulmonary arterial hypertension. Cardiovasc Res 2011, 90:373-382. 10.1093/cvr/cvq408, 21177701.
19. Merklinger SL, Wagner RA, Spiekerkoetter E, Hinek A, Knutsen RH, Kabir MG, Desai K, Hacker S, Wang L, Cann GM, et al. Increased fibulin-5 and elastin in S100A4/Mts1 mice with pulmonary hypertension. Circulation Research 2005, 97:596-604. 10.1161/01.RES.0000182425.49768.8a, 16109920.
20. Spiekerkoetter E, Alvira CM, Kim YM, Bruneau A, Pricola KL, Wang L, Ambartsumian N, Rabinovitch M. Reactivation of gammaHV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin. Am J Physiol Lung Cell Mol Physiol 2008, 294:L276-L289.
21. MacLean MR, Deuchar GA, Hicks MN, Morecroft I, Shen SB, Sheward J, Colston J, Loughlin L, Nilsen M, Dempsie Y, et al. Overexpression of the 5-hydroxytryptamine transporter gene - Effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension. Circulation 2004, 109:2150-2155. 10.1161/01.CIR.0000127375.56172.92, 15078799.
22. Tarin JJ, Gomez-Piquer V, Rausell F, Hermenegildo C, Cano A. Effect of delayed breeding on the reproductive performance of female mice. Reproduction Fertility and Development 2004, 16:373-378.
23. Dempsie Y, Morecroft I, Welsh DJ, Macritchie NA, Herold N, Loughlin L, Nilsen M, Peacock AJ, Harmar A, Bader M, et al. Converging evidence in support of the serotonin hypothesis of dexfenfluramine-induced pulmonary hypertension with novel transgenic mice. Circulation 2008, 117:2928-2937. 10.1161/CIRCULATIONAHA.108.767558, 18506000.
24. Ahn BH, Park HK, Cho HG, Lee HA, Lee YM, Yang EK, Lee WJ. Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats. J Korean Med Sci 2003, 18:641-648. 3055117, 14555814.
25. Said SI, Hamidi SA, Dickman KG, Szema AM, Lyubsky S, Lin RZ, Jiang YP, Chen JJ, Waschek JA, Kort S. Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. Circulation 2007, 115:1260-1268.
26. Tofovic SP, Zhang XC, Jackson EK, Dacic S, Petrusevska G. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension. Vascular Pharmacology 2006, 45:358-367. 10.1016/j.vph.2006.05.007, 16872912.
27. Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity. Cancer Res 2000, 60:3440-3444.
28. Swaneck GE, Fishman J. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization. Proc Natl Acad Sci USA 1988, 85:7831-7835. 10.1073/pnas.85.21.7831, 282290, 3186693.
29. White K, Loughlin L, Maqbool Z, Nilsen M, McClure J, Dempsie Y, Baker AH, MacLean MR. Serotonin transporter, sex, and hypoxia: microarray analysis in the pulmonary arteries of mice identifies genes with relevance to human PAH. Physiol Genomics 2011, 43:417-437. 10.1152/physiolgenomics.00249.2010, 21303932.
30. Austin ED, Cogan JD, West JD, Hedges LK, Hamid R, Dawson EP, Wheeler LA, Parl FF, Loyd JE, Phillips JA. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J 2009, 34:1093-1099. 10.1183/09031936.00010409, 19357154.